Alabama Teen Secures Experimental Cancer Treatment Access After Rapid Federal Intervention

(DailyAnswer.org) – Alabama teen’s desperate plea for experimental cancer treatment reaches President Trump’s inner circle, securing miraculous three-hour approval that bypassed months of red tape.

Story Highlights

15-year-old Will Roberts from rural Alabama battles stage-four osteosarcoma after losing half his leg and facing liver metastasis.
Viral video plea on April 23, 2026, tags Trump and RFK Jr., sparking national support and over $253,000 in GoFundMe donations.
Businessman Ric Mayers connects family to CMS Administrator Dr. Mehmet Oz, granting DeltaRex-G access in record three hours.
Family plans travel to Santa Monica for treatment, highlighting faith, community power, and Trump administration responsiveness.

Will Roberts’ Brave Fight Against Osteosarcoma

Will Roberts, a 15-year-old from Ralph in Tuscaloosa County, Alabama, received a stage-four osteosarcoma diagnosis in January 2025. This rare bone cancer targets children and teens, striking long bones like the leg. Will completed initial chemotherapy, ringing the remission bell mid-2025. Cancer recurred aggressively by late 2025, spreading to his liver and requiring amputation of half his leg. Standard treatments failed, leaving the family desperate for options. Brittney Roberts, Will’s mother, researched DeltaRex-G, a targeted gene therapy in trials for sarcomas developed in Santa Monica.

Viral Plea Ignites National Momentum

Local reporter Rick Karle posted Will’s heartfelt video plea on social media early April 23, 2026, tagging President Donald Trump, HHS Secretary Robert F. Kennedy Jr., and Alabama senators. The video exploded virally by April 24, reaching millions and inspiring prayers nationwide. A GoFundMe campaign, “Rally for Will’s Cancer Journey,” launched that day, raising over $253,000 toward a $600,000 goal covering travel, hospital stays, and lost family income. Will’s selflessness shone through; having lost six friends to cancer, he expressed hope DeltaRex-G could help other children.

Swift Intervention from Trump Administration Allies

West Alabama businessman Ric Mayers, a Trump ally, leveraged connections to reach Dr. Mehmet Oz, CMS Administrator. On April 24-25, Oz personally contacted DeltaRex-G developers, securing special compassionate use approval in just three hours—bypassing the typical six-month process. A telehealth call confirmed access, and the family prepared to travel to Santa Monica. This rapid response underscores the Right to Try Act’s potential when political will aligns with innovation, cutting through bureaucratic delays that often doom patients like Will.

Trump administration appointees like Oz and RFK Jr. emphasize health breakthroughs, contrasting past regulatory hurdles under previous regimes. Conservatives applaud this as limited government enabling individual liberty in life-or-death medical choices. Even skeptics on the left recognize elite networks’ role, fueling shared frustration with a federal system that prioritizes process over people. Will’s story proves grassroots faith and viral advocacy can move mountains when leaders listen.

Broader Hope for Cancer Families

As of April 25, 2026, Will awaits treatment start post-travel, with fundraising ongoing to meet full costs. Short-term, access offers life extension potential amid ~30% post-recurrence survival odds for osteosarcoma. Long-term, success could expand DeltaRex-G trials, pressuring FDA for faster pediatric approvals. Communities rally, from Tuscaloosa donors to national prayer chains, modeling social media’s power against elite gatekeeping. This victory reinforces American values of perseverance, community, and bold leadership reclaiming the American Dream from failing institutions.